Rosuvastatin is a potent statin drug that works by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. This action significantly lowers LDL cholesterol and, more critically for longevity, Apolipoprotein B (ApoB) — the primary protein component of atherogenic lipoproteins. By reducing the number of these causal particles in circulation, rosuvastatin directly mitigates the progression of atherosclerotic cardiovascular disease (ASCVD), a leading cause of age-related mortality and morbidity.
Verdict
A foundational tool for managing ApoB and preventing cardiovascular disease.
HEALTHSPAN IMPACT
Foundational
RISK LEVEL
Moderate
EVIDENCE GRADE
A
MONTHLY COST
$5 - $20
Protocol
- Longevity protocols often use 5-10 mg daily or every other day to manage ApoB.
Flags
- Potential for muscle pain (myalgia) is the most common side effect.
- Slightly increases risk of developing type 2 diabetes in susceptible individuals.